瑞阳制药有限公司基本信息

瑞阳制药有限公司创建于1966年，目前总资产达30亿元，员工超过4000人。公司总部设在山东沂源，并在上海松江区设有分公司，在总部、济南、上海和美国设有研发中心。160多个办事处遍布国内大中城市，产品已覆盖全国，并远销德国、法国、韩国等三十多个国家。
        瑞阳的业务领域主要包括药品的研发与制造。涉及粉针制剂、原料药、固体制剂和中药制剂的生产和研发，以及抗癌药物、新的抗生素类药物、防疫疫苗和治疗疫苗等的研发。是全国最大的头孢类原料药生产基地之一，粉针生产规模全国前五，其梅洛西林钠原料药及其制剂。同时，与清华大学、山东大学等30多家高校和科研机构有着常年科研合作关系，拥有大量专利产品，获得国家科技进步奖，承担国家级项目5项，并负责起草了42个新药产品的国家药品标准。
        四十多年来，秉承“瑞阳制药，造福四方”的宗旨，瑞阳制药有限公司重视新产品、新技术的开发，以严密的质保体系为保障，保持效益持续稳定的增长，并积极参与社会公益事业，位列中国领先的制药工业企业前20强。在未来，瑞阳制药将继续以优质的产品造福社会。
        随着公司的发展，我们将不断创造高质量的就业机会，诚邀有志之士加盟我们的团队。
Reyoung Pharmaceutical Co., Ltd, which was converted into a limited company under the PRC law in 1998 and is now a Singapore-listed company, was established in 1966. The company is an ISO9001、ISO14001、OHS18001 authentication enterprise and possess postdoctoral programme and ERP system and so on. The trademark of “reyoung” is famous trademark of China.
reyoung
It covers an area of more than 343,000 square meters, with the total asset of USD100 millions. There is more than 4000 staff in Reyoung Pharm., of whom approximate 21 percents of the total staff is sales&marketing personnel. All the workshops, which can produce eight categories and more than 340 specifications of pharmaceutical products including tablets, capsules, granules, sterile active ingredients, small volume injection, powder for injection, lyophilized powder for injection, suppository, have passed GMP certification of the Chinese SFDA. The sales and marketing network for its products covers all the big and medium cities throughout the mainland of PRC.Total assets have been more than 30 billion.
公司网站：